News in Polymer analysis: The new Multi-Shot EGA/PY-3030D pyrolyzer
Shimadzu and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu's GCMS-QP2010 quadrupole series and Frontier Lab's new Multi-Shot EGA/PY-3030D vertical micro furnace pyrolyzer.
Shimadzu and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu’s GCMS-QP2010 quadrupole series and Frontier Lab’s new Multi-Shot EGA/PY-3030D vertical micro furnace pyrolyzer. Both companies have teamed up in Pyrolysis-GCMS for years.
The PY-3030D is equipped with a low thermal mass ceramic heater featuring improved thermal stability and an extended temperature range from ambient + 10 °C to1050 °C. This enables the analysis of temperature-sensitive compounds as well as the cracking of highly temperature-stable polymers using high-temperature pyrolysis. The low mass ceramic heater and the new design of the pyrolysis/GC interface contribute to increased heating and cooling rates, leading to higher productivity because of very short heater cycle times.
Optimized temperature control ensures increased reproducibility of pyrolysis data, particularly at higher temperatures. In addition, the outstanding performance of the GCMS-QP2010 series contributes to the excellent reproducibility of the data.
The wide range of new accessories opens up new potentials for the analysis of polymers – a configuration is available for nearly every analytical challenge. The sample introduction systems offer increased application possibilities including the analysis of weathering products and reactions at high pressure. By simply changing the sampler, different sample introduction methods such as single-shot/double-shot pyrolysis, liquid injection, reactive pyrolysis or sample irradiation with UV light can be selected.
For further details please visit www.shimadzu.eu
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
